1. Home
  2. XNCR vs NYMT Comparison

XNCR vs NYMT Comparison

Compare XNCR & NYMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • NYMT
  • Stock Information
  • Founded
  • XNCR 1997
  • NYMT 2003
  • Country
  • XNCR United States
  • NYMT United States
  • Employees
  • XNCR N/A
  • NYMT N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • NYMT Real Estate Investment Trusts
  • Sector
  • XNCR Health Care
  • NYMT Real Estate
  • Exchange
  • XNCR Nasdaq
  • NYMT Nasdaq
  • Market Cap
  • XNCR 579.3M
  • NYMT 583.3M
  • IPO Year
  • XNCR 2013
  • NYMT 2004
  • Fundamental
  • Price
  • XNCR $7.90
  • NYMT $6.70
  • Analyst Decision
  • XNCR Buy
  • NYMT Strong Buy
  • Analyst Count
  • XNCR 7
  • NYMT 4
  • Target Price
  • XNCR $27.50
  • NYMT $8.17
  • AVG Volume (30 Days)
  • XNCR 800.2K
  • NYMT 716.1K
  • Earning Date
  • XNCR 08-04-2025
  • NYMT 07-30-2025
  • Dividend Yield
  • XNCR N/A
  • NYMT 11.98%
  • EPS Growth
  • XNCR N/A
  • NYMT N/A
  • EPS
  • XNCR N/A
  • NYMT N/A
  • Revenue
  • XNCR $127,228,000.00
  • NYMT $192,556,000.00
  • Revenue This Year
  • XNCR N/A
  • NYMT $6.23
  • Revenue Next Year
  • XNCR $28.84
  • NYMT $12.09
  • P/E Ratio
  • XNCR N/A
  • NYMT N/A
  • Revenue Growth
  • XNCR N/A
  • NYMT 14.89
  • 52 Week Low
  • XNCR $7.16
  • NYMT $5.02
  • 52 Week High
  • XNCR $27.24
  • NYMT $7.27
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 44.24
  • NYMT 50.06
  • Support Level
  • XNCR $7.88
  • NYMT $6.34
  • Resistance Level
  • XNCR $8.80
  • NYMT $6.99
  • Average True Range (ATR)
  • XNCR 0.53
  • NYMT 0.16
  • MACD
  • XNCR -0.05
  • NYMT -0.04
  • Stochastic Oscillator
  • XNCR 22.41
  • NYMT 38.67

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About NYMT New York Mortgage Trust Inc.

New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets. Geographically operates in USA states California, New York, Florida, New Jersey, Illinois, maximum from California.

Share on Social Networks: